#HealthCanada, #AbbotLaboratories, #IDNOWRapidCOVID19TestingDevice
Ottawa, Oct 1 (Canadian-Media): Health Canada's approval Sep 30 of Abbott Laboratories-backed point-of-care ID NOW rapid COVID-19 testing device for Canada could result in millions more tests for communities combating with a surge in coronavirus cases, media reports said.
Image credit: ID NOW rapid COVID-19 testing device
Since these devices can be administered by trained professionals at places like pharmacies, walk-in clinics and doctors' offices and give the results in 15 minutes, and avoids an extra step of sending the samples to laboratory to determine the results.
Canada's Prime Minister Justin Trudeau said Sep 30 during his question period said the government is expecting to receive the first batch of these Abbott tests "in the coming weeks," and added that the government has earmarked more money for Health Canada to expedite the approvals process for "new technologies" like these diagnostic devices.
Abbott has already shipped more than 11 million ID NOW tests to all 50 U.S. states, Washington D.C. and the U.S. territories.
When health experts and the opposition Conservatives pointed out Health Canada's delay regulatory process, Trudeau said his government put "science first" to protect Canadians from faulty devices as some researchers had said that this Abbott device has led to false positives in a small number of cases.